We provide competitive pricing, automated workflows, and reliable delivery to healthcare providers across the U.S
Wegovy, Ozempic and GLP1- inhibitors have arguably become the most popular medications in the modern world
Microdosing GLP-1 lacks clinical trial evidence and regulatory approval, making its safety profile unknown
Most clinical trials reporting weight loss outcomes involved people taking 2.4 mg of semaglutide, the maximum dose of Wegovy (a version of semaglutide thats specifically indicated for weight loss)
Live enzyme tests assess liver health as some patients may experience elevated liver enzymes while on the medication (like ALT and AST) Lipid panel tracks cardiovascular risk factors, including total cholesterol, LDL (bad), HDL (good), and triglycerides